PT Murni Sadar Tbk (MTMH.JK)
IDR 850.0
(-3.41%)
IDR 850.0
(-3.41%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 15.2 Billion IDR | -86.49% |
| 2022 | 112.51 Billion IDR | -62.7% |
| 2021 | 301.62 Billion IDR | 446.8% |
| 2020 | 55.16 Billion IDR | 253.5% |
| 2019 | -35.93 Billion IDR | -400.89% |
| 2018 | 11.94 Billion IDR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 29.85 Billion IDR | 167.94% |
| 2024 Q2 | 11.14 Billion IDR | -26.97% |
| 2024 Q1 | 15.25 Billion IDR | 638.26% |
| 2023 Q2 | -9.2 Billion IDR | -166.67% |
| 2023 Q3 | 20.37 Billion IDR | 321.28% |
| 2023 Q4 | -2.83 Billion IDR | -113.92% |
| 2023 Q1 | 13.8 Billion IDR | -62.63% |
| 2023 FY | 15.2 Billion IDR | -86.49% |
| 2022 FY | 112.51 Billion IDR | -62.7% |
| 2022 Q4 | 36.95 Billion IDR | 263.57% |
| 2022 Q2 | 15.02 Billion IDR | -70.15% |
| 2022 Q1 | 50.33 Billion IDR | 193.34% |
| 2022 Q3 | 10.16 Billion IDR | -32.36% |
| 2021 Q1 | 108.99 Billion IDR | 0.0% |
| 2021 Q3 | 64.9 Billion IDR | -40.45% |
| 2021 Q2 | 108.99 Billion IDR | 0.0% |
| 2021 FY | 301.62 Billion IDR | 446.8% |
| 2021 Q4 | -53.93 Billion IDR | -183.09% |
| 2020 FY | 55.16 Billion IDR | 253.5% |
| 2019 FY | -35.93 Billion IDR | -400.89% |
| 2018 FY | 11.94 Billion IDR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| PT Bundamedik Tbk | 211.43 Billion IDR | 92.808% |
| PT Metro Healthcare Indonesia Tbk | -36.13 Billion IDR | 142.077% |
| PT Medikaloka Hermina Tbk | 780.69 Billion IDR | 98.052% |
| PT Mitra Keluarga Karyasehat Tbk | 1207.01 Billion IDR | 98.74% |
| PT Famon Awal Bros Sedaya Tbk | 204.41 Billion IDR | 92.561% |
| PT Royal Prima Tbk | -4.62 Billion IDR | 428.989% |
| PT Kedoya Adyaraya Tbk | 29.49 Billion IDR | 48.45% |
| PT Sarana Meditama Metropolitan Tbk | 47.32 Billion IDR | 67.87% |
| PT Siloam International Hospitals Tbk | 1728.28 Billion IDR | 99.12% |
| PT Sejahteraraya Anugrahjaya Tbk | 106.26 Billion IDR | 85.69% |